Najmeh Dorraki, Zari Naderi Ghale-Noie, Nooshin Sadegh Ahmadi, Vahideh Keyvani, Rosita Azar Bahadori, Arash Salmani Nejad, Michael Aschner, Hossein Pourghadamyari, Samaneh Mollazadeh, Hamed Mirzaei
Journal: Epigenomics 2022;13(24):1939-1960
PMID: 34852637
miRNA-148b belongs to the family miR-148/-152, with significant differences in nonseed sequences, which can target diverse mRNA molecules. Reportedly, it may undergo deregulation in lung and ovarian cancers and downregulation in gastric, pancreatic and colon cancers. However, there is a need for further studies to better characterize its mechanism of action and in different types of cancer. In this review, we focus on the aberrant expression of miR-148b in different cancer types and highlight its main target genes and signaling pathways, as well as its pathophysiologic role and relevance to tumorigenesis in several types of cancer.
Medical:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.